Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Cash: 2020-2025

Historic Change in Cash for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $4.7 million.

  • Journey Medical's Change in Cash rose 420.81% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 208.70%. This contributed to the annual value of -$7.1 million for FY2024, which is 56.31% down from last year.
  • Per Journey Medical's latest filing, its Change in Cash stood at $4.7 million for Q3 2025, which was up 699.10% from -$777,000 recorded in Q2 2025.
  • Journey Medical's 5-year Change in Cash high stood at $27.4 million for Q4 2021, and its period low was -$9.1 million during Q2 2023.
  • Over the past 3 years, Journey Medical's median Change in Cash value was -$777,000 (recorded in 2025), while the average stood at -$641,364.
  • As far as peak fluctuations go, Journey Medical's Change in Cash spiked by 527.25% in 2021, and later slumped by 435.86% in 2025.
  • Journey Medical's Change in Cash (Quarterly) stood at $27.4 million in 2021, then crashed by 110.54% to -$2.9 million in 2022, then spiked by 193.14% to $2.7 million in 2023, then plummeted by 180.15% to -$2.2 million in 2024, then soared by 420.81% to $4.7 million in 2025.
  • Its Change in Cash was $4.7 million in Q3 2025, compared to -$777,000 in Q2 2025 and $765,000 in Q1 2025.